Breast Implant-Associated Anaplastic Large Cell Lymphoma Following Gender Reassignment Surgery: A Review of Presentation, Management, and Outcomes in the Transgender Patient Population
Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is a rare peripheral T-cell lymphoma with approximately 650-700 reported cases worldwide. The incidence, however, is increasing as more practitioners become aware of the diagnosis, and recent studies show that early diagnosis and tr...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Galenos Publishing House
2020-07-01
|
| Series: | European Journal of Breast Health |
| Subjects: | |
| Online Access: |
http://www.eurjbreasthealth.com/archives/archive-detail/article-preview/breast-mplant-associated-anaplastic-large-cell-lym/41902
|
| _version_ | 1797908638842486784 |
|---|---|
| author | Shruti Zaveri Alice Yao Hank Schmidt |
| author_facet | Shruti Zaveri Alice Yao Hank Schmidt |
| author_sort | Shruti Zaveri |
| collection | DOAJ |
| description | Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is a rare peripheral T-cell lymphoma with approximately 650-700 reported cases worldwide. The incidence, however, is increasing as more practitioners become aware of the diagnosis, and recent studies show that early diagnosis and treatment is critical to improve prognosis. There have been four cases of BIA-ALCL in total reported in the transgender population in the literature. These reported cases were reviewed in detail to determine presentation and management of BIA-ALCL in transgender patients compared to the larger population of BIA-ALCL patients. This review highlights BIA-ALCL in transgender women, a population that is often excluded from breast screening and follow-up. Transgender women may not routinely go through the same post-operative follow-up protocols as patients with breast implants for breast cancer reconstruction and can thus be at risk for delayed recognition and diagnosis. BIA-ALCL is a rare complication of breast implantation, and it is important to counsel all patients undergoing implant placement, including transgender women, on its risk. |
| first_indexed | 2024-04-10T10:55:38Z |
| format | Article |
| id | doaj.art-c0834994c4944f9998ca1a6470d43497 |
| institution | Directory Open Access Journal |
| issn | 2587-0831 |
| language | English |
| last_indexed | 2024-04-10T10:55:38Z |
| publishDate | 2020-07-01 |
| publisher | Galenos Publishing House |
| record_format | Article |
| series | European Journal of Breast Health |
| spelling | doaj.art-c0834994c4944f9998ca1a6470d434972023-02-15T16:20:00ZengGalenos Publishing HouseEuropean Journal of Breast Health2587-08312020-07-0116316216610.5152/ejbh.2020.548013049054Breast Implant-Associated Anaplastic Large Cell Lymphoma Following Gender Reassignment Surgery: A Review of Presentation, Management, and Outcomes in the Transgender Patient PopulationShruti Zaveri0Alice Yao1Hank Schmidt2 Department of Surgery, The Mount Sinai Hospital, New York, NY, USA Division of Plastic and Reconstructive Surgery, Department of Surgery, The Mount Sinai Hospital, New York, NY, USA Dubin Breast Center, Tisch Cancer Institute, The Mount Sinai Hospital, New York, NY, USA Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is a rare peripheral T-cell lymphoma with approximately 650-700 reported cases worldwide. The incidence, however, is increasing as more practitioners become aware of the diagnosis, and recent studies show that early diagnosis and treatment is critical to improve prognosis. There have been four cases of BIA-ALCL in total reported in the transgender population in the literature. These reported cases were reviewed in detail to determine presentation and management of BIA-ALCL in transgender patients compared to the larger population of BIA-ALCL patients. This review highlights BIA-ALCL in transgender women, a population that is often excluded from breast screening and follow-up. Transgender women may not routinely go through the same post-operative follow-up protocols as patients with breast implants for breast cancer reconstruction and can thus be at risk for delayed recognition and diagnosis. BIA-ALCL is a rare complication of breast implantation, and it is important to counsel all patients undergoing implant placement, including transgender women, on its risk. http://www.eurjbreasthealth.com/archives/archive-detail/article-preview/breast-mplant-associated-anaplastic-large-cell-lym/41902 bia-alclimplantlymphomatransgender |
| spellingShingle | Shruti Zaveri Alice Yao Hank Schmidt Breast Implant-Associated Anaplastic Large Cell Lymphoma Following Gender Reassignment Surgery: A Review of Presentation, Management, and Outcomes in the Transgender Patient Population European Journal of Breast Health bia-alcl implant lymphoma transgender |
| title | Breast Implant-Associated Anaplastic Large Cell Lymphoma Following Gender Reassignment Surgery: A Review of Presentation, Management, and Outcomes in the Transgender Patient Population |
| title_full | Breast Implant-Associated Anaplastic Large Cell Lymphoma Following Gender Reassignment Surgery: A Review of Presentation, Management, and Outcomes in the Transgender Patient Population |
| title_fullStr | Breast Implant-Associated Anaplastic Large Cell Lymphoma Following Gender Reassignment Surgery: A Review of Presentation, Management, and Outcomes in the Transgender Patient Population |
| title_full_unstemmed | Breast Implant-Associated Anaplastic Large Cell Lymphoma Following Gender Reassignment Surgery: A Review of Presentation, Management, and Outcomes in the Transgender Patient Population |
| title_short | Breast Implant-Associated Anaplastic Large Cell Lymphoma Following Gender Reassignment Surgery: A Review of Presentation, Management, and Outcomes in the Transgender Patient Population |
| title_sort | breast implant associated anaplastic large cell lymphoma following gender reassignment surgery a review of presentation management and outcomes in the transgender patient population |
| topic | bia-alcl implant lymphoma transgender |
| url |
http://www.eurjbreasthealth.com/archives/archive-detail/article-preview/breast-mplant-associated-anaplastic-large-cell-lym/41902
|
| work_keys_str_mv | AT shrutizaveri breastimplantassociatedanaplasticlargecelllymphomafollowinggenderreassignmentsurgeryareviewofpresentationmanagementandoutcomesinthetransgenderpatientpopulation AT aliceyao breastimplantassociatedanaplasticlargecelllymphomafollowinggenderreassignmentsurgeryareviewofpresentationmanagementandoutcomesinthetransgenderpatientpopulation AT hankschmidt breastimplantassociatedanaplasticlargecelllymphomafollowinggenderreassignmentsurgeryareviewofpresentationmanagementandoutcomesinthetransgenderpatientpopulation |